To compare the usefulness between two different chest blocks for pain relief in patients posted for chest surgery

Comparing erector spinae plane block and serratus anterior plane block for quality of recovery in patients posted for thoracotomy A prospective randomised double blinded controlled study - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068661

Enrollment

120

Registered

2024-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: J99- Respiratory disorders in diseasesclassified elsewhere

Interventions

Intervention1: Erector spinae plane block: Group ESP will receive 0.375% ropivacaine(0.5 ml/kg) with general anaesthesia to assess the quality of recovery(QOR) at 24 hours. Control Intervention1: Serr

Eligibility

Inclusion criteria

Inclusion criteria: Patients age between 18-70 years of either sex Patients able to comprehend and willing to participate ASA physical status l-lll Patients scheduled to undergo for unilateral thoracotomy under general anaesthesia

Exclusion criteria

Exclusion criteria: Patients refusal to participate Allergy to local anaesthetics Chronic opioid use or history of chronic pain Infection at block site Cognitive dysfunction or psychiatric illness

Design outcomes

Primary

Measure	Time frame
Primary outcome is to assess quality of recovery using QOR-15 scale at 24 hours postoperatively.Timepoint: Postoperative 24 hours	—

Secondary

Measure	Time frame
To assess pain score using NRS scale upto 24 hours,time to rescue analgesia use,total analgesic consumption upto 24 hours,patients satisfaction and any adverse effects seen.Timepoint: Pain score will be recorded at rest and during coughing using NRS scores at 0,3,6,12,18 and 24 hours.	—

Countries

India

Contacts

Public ContactDR ALOK KUMAR BHARTI

Indira Gandhi Institute of Medical Sciences

chandrashekhar613@gmail.com6201575759

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026